Transplantation, AutologousStem Cell TransplantationHematopoietic Stem Cell TransplantationStem CellsMelphalanMultiple MyelomaCombined Modality TherapyPeripheral Blood Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem CellsRemission InductionSalvage TherapyTransplantation ConditioningEtoposideThiotepaTreatment OutcomeHematopoietic Stem Cell MobilizationHodgkin DiseaseDisease-Free SurvivalLymphoma, Non-HodgkinCarmustineBone Marrow PurgingCytarabineCyclophosphamideVincristineEmbryonic Stem CellsAdult Stem CellsAmyloidosisRecurrenceMyeloablative AgonistsLymphoma, Mantle-CellSurvival RateBoronic AcidsPyrazinesDexamethasonePluripotent Stem CellsLymphoma, T-Cell, PeripheralThalidomideLymphoma, FollicularDoxorubicinAntigens, CD34Antibodies, Monoclonal, Murine-DerivedSurvival AnalysisMesenchymal Stem Cell TransplantationBone Marrow TransplantationIfosfamideAutograftsStem Cell NicheCell DifferentiationMesenchymal Stromal CellsWhole-Body IrradiationAntineoplastic Agents, AlkylatingInduced Pluripotent Stem CellsTransplantation, HomologousNeural Stem CellsRetrospective StudiesPrognosisLeukapheresisPodophyllotoxinGranulocyte Colony-Stimulating FactorInduction ChemotherapyPrednisoneFollow-Up StudiesBusulfanLymphoma, Large B-Cell, DiffuseLymphomaMultipotent Stem CellsBlood Transfusion, AutologousMaintenance ChemotherapyLymphoma, B-CellStem Cell FactorMitoxantroneTime FactorsEnteropathy-Associated T-Cell LymphomaBone Marrow CellsCells, CulturedAntineoplastic AgentsNeoplasm, ResidualGraft SurvivalInfusions, SpinalBlood Component RemovalLeukemia, Plasma CellCarboplatinHematologic NeoplasmsIdarubicinRadioimmunotherapyCell LineageImmunoglobulin Light ChainsNeoplasms, Second PrimaryBone MarrowHematopoiesisKeratins, Type IILife TablesStem Cell ResearchFeasibility StudiesMedulloblastomaMucositisAntibodies, MonoclonalPlant StemsFlow Cytometry